More Protagonist Therapeutics, Inc. news Protagonist Therapeutics, Inc.NASDAQ: PTGX DELETED: Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice Nov 27, 2025 · Issued by Protagonist Therapeutics, Inc. As issuedPlain English Watch Protagonist Therapeutics explain it↗Protagonist Therapeutics, Inc. (PTGX) Q4 2020 Earnings Call · Replay · Mar 10, 2021This story has been deleted by the news provider.